bpc-157 tumor growth – No Proof Required! | Office for Science and Society Body Protecting Compound 157 (BPC-157
Description
All treatments require provider evaluation
doi: 10.1161/CIRCULATIONAHA.109.904672
10.3390/cancers14143538 136 SvensonK
The FDA has not reviewed safety data, efficacy data, or quality control standards for these mixed formulations
Whilst mTORC1 activates S6 kinase, which phosphorylates serine residues on IRS which in turn uncouples IRS from the receptor and its substrates, mTORC2 can reactivate this signalling
The combination of 5-Amino-1MQ + BPC-157 (Weight Loss Blend) and SLU-PP-332 targets the root causes of weight gain and fatigue at the cellular level
